Why Is Trigeminal Neuralgia Called the Suicide Disease?

Trigeminal neuralgia is called the “suicide disease” because it causes what many patients and physicians consider the most severe pain known to medicine, and that pain has historically driven some sufferers to take their own lives. The label reflects both the extraordinary intensity of the condition and its devastating psychological toll. Recent research shows the name isn’t just historical: over a third of patients report at least some thoughts of suicide within a given two-week period, and nearly 58% report thinking about their own death.

What the Pain Actually Feels Like

Trigeminal neuralgia produces sudden, electric-shock-like bursts of pain on one side of the face. Each attack lasts anywhere from a few seconds to two minutes, but the frequency can range from a handful of episodes a day to hundreds. The pain is often described as a lightning bolt or stabbing sensation concentrated along the jaw, cheek, or forehead, following the path of the trigeminal nerve, which is the main sensory nerve of the face.

What makes this condition uniquely disabling is that everyday activities trigger the attacks. Light touch is the most common trigger. In studies of patients with the condition, 67% reported that brushing their teeth triggered an attack. Talking set off pain in 65% of patients. Washing the face triggered episodes in 37%. Even weather plays a role: about 20% of patients reported attacks triggered by strong winds, cold air, or cold temperatures. Eating, smiling, shaving, and applying makeup can all provoke an episode. The result is that patients begin avoiding the most basic parts of daily life.

The Psychological Toll Behind the Name

A 2025 study published in a peer-reviewed psychiatry journal examined suicidal thoughts and depression among people living with trigeminal neuralgia, and the numbers are striking. Of the patients surveyed, 34.6% reported at least some thoughts of suicide in the previous two weeks. Nearly 28% said they had thought the world would be better off without them. More than half, 57.7%, reported thinking about their own death. About 28.5% of respondents scored high enough on depression measures to likely meet the criteria for a clinical depression diagnosis.

These numbers help explain why the “suicide disease” label has persisted. The pain is not just severe in the moment. It is unpredictable, can strike dozens or hundreds of times a day, and makes patients afraid to eat, speak, or go outside. That combination of intensity, frequency, and loss of normal life creates a psychological burden that goes far beyond what most chronic pain conditions produce.

Should the Name Still Be Used?

Despite its historical accuracy, some researchers and patient advocates now argue the label does more harm than good. A recent paper in the journal European Psychiatry noted that calling trigeminal neuralgia the “suicide disease” may harm patients’ understanding and acceptance of their diagnosis. It can also increase fear and stress about what the future holds, particularly for people who are newly diagnosed and searching for information online. The concern is that the name frames the condition as hopeless when, in reality, effective treatments exist for many patients.

What Causes Trigeminal Neuralgia

In 80% to 90% of cases, trigeminal neuralgia is caused by a blood vessel pressing against the trigeminal nerve root near the brainstem. The superior cerebellar artery is the culprit in roughly 75% to 80% of those cases. Over time, the pulsing of the artery against the nerve damages its protective insulating layer (myelin), causing the nerve to misfire. Signals that should register as harmless, like a breeze on the cheek, instead produce extreme pain.

In a smaller number of cases, the condition is linked to multiple sclerosis, which also damages the myelin coating of nerves. Studies estimate that roughly 4% to 10% of people with MS develop trigeminal neuralgia over the course of their disease. In some patients, facial pain is actually the first symptom that eventually leads to an MS diagnosis. Rarely, tumors or other structural problems near the brainstem can also compress the nerve.

How It Is Treated

The first line of treatment is medication that calms overactive nerve signaling. The most commonly prescribed drug reduces pain by stabilizing the nerve membrane so it doesn’t fire as easily. Patients typically start on a low dose that is gradually increased until the pain is controlled, with most people taking doses well below the maximum. For many patients, this provides significant relief, at least initially. Over time, however, some people find the medication becomes less effective or produces side effects like drowsiness and dizziness that are hard to tolerate.

When medication stops working or causes intolerable side effects, surgery becomes an option. The most effective procedure is microvascular decompression, in which a surgeon places a small cushion between the offending blood vessel and the trigeminal nerve. This addresses the root cause rather than masking symptoms. Between 58% and 68% of patients remain pain-free 8 to 10 years after the procedure. Less invasive options, including targeted radiation and procedures that intentionally damage a small portion of the nerve to interrupt pain signals, are also available for patients who aren’t candidates for open surgery. These tend to have higher recurrence rates but involve shorter recovery times.

Why Diagnosis Often Takes Too Long

One of the most frustrating aspects of trigeminal neuralgia is how long it takes to get a correct diagnosis. Because the pain is concentrated in the face, jaw, and teeth, many patients are initially told they have a dental problem. Some undergo unnecessary root canals, tooth extractions, or sinus treatments before anyone considers a neurological cause. The pain’s sudden, episodic nature can also lead to misdiagnosis as a migraine disorder or temporomandibular joint dysfunction. This diagnostic delay prolongs suffering and can deepen the psychological impact, since patients feel dismissed or confused about what is happening to them.

The condition is also relatively rare, which means many general practitioners have limited experience recognizing it. A key distinguishing feature is that the pain is triggered by light touch or routine activities rather than occurring spontaneously, and that each burst of pain is very brief. If you experience repeated, shock-like facial pain that lasts seconds at a time and is provoked by touching your face, eating, or talking, those details are worth communicating clearly to your doctor, as they point specifically toward trigeminal neuralgia and away from dental or migraine diagnoses.